Other ingredients Purified water, l-glutathione, glycerine, glyceryl dilaurate, cetearyl alcohol, glyceryl stearate, peg-100 stearate, ceteareth-20, isopropyl myristate, guar gum, imidurea nf, methyl paraben, propyl paraben
Add your clinical experience in the comments for community discussion
Consult a healthcare professional before use during pregnancy or breastfeeding
Cagrilintide clinical trial results The phase 2 dose-finding trial enrolled participants with overweight or obesity and tested cagrilintide doses ranging from 0.3 mg to 4.5 mg administered subcutaneously once weekly
The inhibition of TRPV1-driven HCK migration by L-carnitine shown in Fig